Literature DB >> 12540771

Nonalcoholic steatohepatitis clinical research network.

.   

Abstract

Entities:  

Mesh：

Year:  2003        PMID： 12540771     DOI： 10.1002/hep.510370203

Source DB:  PubMed          Journal:  Hepatology        ISSN： 0270-9139            Impact factor:   17.425


× No keyword cloud information.
  20 in total

1.  Regional anthropometric measures and hepatic fibrosis in patients with nonalcoholic Fatty liver disease.

Authors:  Ayako Suzuki; Manal F Abdelmalek; Aynur Unalp-Arida; Katherine Yates; Arun Sanyal; Cynthia Guy; Anna Mae Diehl
Journal:  Clin Gastroenterol Hepatol       Date:  2010-08-20       Impact factor: 11.382

Review 2.  Nonalcoholic fatty liver disease and HIV infection.

Authors:  Raphael B Merriman
Journal:  Curr HIV/AIDS Rep       Date:  2006-09       Impact factor: 5.071

Review 3.  Nonalcoholic steatohepatitis-associated hepatocellular carcinoma: our case series and literature review.

Authors:  Yoshitaka Takuma; Kazuhiro Nouso
Journal:  World J Gastroenterol       Date:  2010-03-28       Impact factor: 5.742

4.  Clinical significance of serum autoantibodies in patients with NAFLD: results from the nonalcoholic steatohepatitis clinical research network.

Authors:  Raj Vuppalanchi; Robert J Gould; Laura A Wilson; Aynur Unalp-Arida; Oscar W Cummings; Naga Chalasani; Kris V Kowdley
Journal:  Hepatol Int       Date:  2011-05-10       Impact factor: 6.047

5.  Ethnicity and nonalcoholic fatty liver disease.

Authors:  Kiran Bambha; Patricia Belt; Maria Abraham; Laura A Wilson; Mark Pabst; Linda Ferrell; Aynur Unalp-Arida; Nathan Bass
Journal:  Hepatology       Date:  2012-03       Impact factor: 17.425

6.  Physical activity recommendations, exercise intensity, and histological severity of nonalcoholic fatty liver disease.

Authors:  Kristin D Kistler; Elizabeth M Brunt; Jeanne M Clark; Anna Mae Diehl; James F Sallis; Jeffrey B Schwimmer
Journal:  Am J Gastroenterol       Date:  2011-01-04       Impact factor: 10.864

7.  A longer duration of estrogen deficiency increases fibrosis risk among postmenopausal women with nonalcoholic fatty liver disease.

Authors:  Jagpal Singh Klair; Ju Dong Yang; Manal F Abdelmalek; Cynthia D Guy; Ryan M Gill; Katherine Yates; Aynur Unalp-Arida; Joel E Lavine; Jeanne M Clark; Anna Mae Diehl; Ayako Suzuki
Journal:  Hepatology       Date:  2016-04-05       Impact factor: 17.425

8.  Effects of low-calorie diet on steatohepatitis in rats with obesity and hyperlipidemia.

Authors:  Jian-Gao Fan; Lan Zhong; Zheng-Jie Xu; Li-Yan Tia; Xiao-Dong Ding; Min-Sheng Li; Guo-Liang Wang
Journal:  World J Gastroenterol       Date:  2003-09       Impact factor: 5.742

9.  Patient Sex, Reproductive Status, and Synthetic Hormone Use Associate With Histologic Severity of Nonalcoholic Steatohepatitis.

Authors:  Ju Dong Yang; Manal F Abdelmalek; Cynthia D Guy; Ryan M Gill; Joel E Lavine; Katherine Yates; Jagpal Klair; Norah A Terrault; Jeanne M Clark; Aynur Unalp-Arida; Anna Mae Diehl; Ayako Suzuki
Journal:  Clin Gastroenterol Hepatol       Date:  2016-08-12       Impact factor: 11.382

10.  Treatment of nonalcoholic fatty liver disease in children: TONIC trial design.

Authors:  Joel E Lavine; Jeffrey B Schwimmer; Jean P Molleston; Ann O Scheimann; Karen F Murray; Stephanie H Abrams; Philip Rosenthal; Arun J Sanyal; Patricia R Robuck; Elizabeth M Brunt; Aynur Unalp; James Tonascia
Journal:  Contemp Clin Trials       Date:  2009-09-15       Impact factor: 2.226
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.